Investor FAQ
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies, Endoscopy, and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.
Smith & Nephew is a global medical technology business, specialising in Orthopaedics, including Reconstruction, Trauma and Clinical Therapies, Endoscopy, and Advanced Wound Management. Smith & Nephew is a global leader in arthroscopy and advanced wound management and is one of the leading global orthopaedics companies.
Smith & Nephew is dedicated to helping improve people's lives. The Company prides itself on the strength of its relationships with its surgeons and professional healthcare customers, with whom its name is synonymous with high standards of performance, innovation and trust. The Company operates in 32 countries around the world. Annual sales in 2008 were $3.8 billion.
Smith & Nephew has operations in 32 countries including the Americas, Europe and Asia.
In 2008 Smith & Nephew had over 9,750 employees.
Smith & Nephew has a focused strategy that has rewarded our shareholders and laid the foundation for continued success. We are No1 in the world in Arthroscopy (minimally invasive surgery of the joint) business segments. We are No. 2 in the Advanced Wound Management market with a reputation for innovation and strength of product range. Our Orthopaedic Reconstruction business is No. 4 in the global market and has a reputation for being one of the most innovative. The Trauma business is No. 3 in the world with leading ranges of internal and external fixation systems.
Smith & Nephew has a focused strategy that has rewarded our shareholders and laid the foundation for continued success. We are No1 in the world in Arthroscopy (minimally invasive surgery of the joint) business segments. We are No. 2 in the Advanced Wound Management market with a reputation for innovation and strength of product range. Our Orthopaedic Reconstruction business is No. 4 in the global market and has a reputation for being one of the most innovative. The Trauma business is No. 3 in the world with leading ranges of internal and external fixation systems.